Mereo BioPharma Group plc (MREO) Reports In-Line Q3 EPS

Mereo BioPharma Group plc (NASDAQ: MREO) reported Q3 EPS of ($0.02), in-line with the analyst estimate of ($0.02).

For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.

You May Also Be Interested In

• Saudi Arabia Oil Pipeline Struck By Projectiles Thursday - CNN
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• Active options: GOOGL AMD SMCI DELL MARA MSFT PLTR HOOD SNDK GME